Search
CN
About us
Our Company
Our Culture
Our History
Pipeline
Therapy
Product&Pipeline
Medicines
Health care
R&D
Complex Product and Platform
Innovative Medicines
Medical Devices
Technical Services(CDMO/CMO)
Partnering
Internationalization
R&D
One-stop service
Provide what you want
News
Press releases
Careers
Join us
Our Employees
Incentives
Opportunities
Investors
Investor contact
Contact us
CN
Home
About us
Our Company
Our Culture
Our History
Pipeline
Therapy
Product&Pipeline
Medicines
Health care
R&D
Complex Product and Platform
Innovative Medicines
Medical Devices
Technical Services(CDMO/CMO)
Partnering
Internationalization
R&D
One-stop service
Provide what you want
News
Press releases
Careers
Join us
Our Employees
Incentives
Opportunities
Investors
Investor contact
Contact us
Home
·
News
·
Press releases
·
Press releases
SCROLL DOWN
Press releases
Press releases
17
2022.11
Good News | CF PharmTech won the "Best Employer of Greater Suzhou" in 2022
4733
Share
On November 17, 2022, the 9th "Best Employers in Greater Suzhou" was officially announced by Suzhou Industrial Park Human Resources Development Co., LTD. With excellent human resource management pract
07
2022.11
Good news from CF PharmTech | The first domestic blockbuster product for the treatment of allergic rhinitis - Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (ShuFeiMin ®) was approved
4430
Share
Today, CF PharmTech, Inc. (hereinafter referred to as: "CF PharmTech") independently developed the heavy product ShuFeiMin® (National drug approval number: H20223778, general
25
2022.07
Announcement of the receipt of the listing notice to
CF PharmTech, Inc.
4154
Share
03
2020.07
CF PharmTech has completed F round of 360 million yuan equity investment to support rapid development of domestic high-end inhalation products.
4123
Share
CF PharmTech, Inc. (CF PharmTech, Inc., referred to as "CF PharmTech"), following the completion of the E round of 630 million financing in January, once again completed the F round of 360 million yuan financing, a total of nearly 1 billion financing with
About us
Our Company
Our Culture
Our History
Pipeline
Therapy
Product&Pipeline
Medicines
Health care
R&D
Complex Product and Platform
Innovative Medicines
Medical Devices
Technical Services(CDMO/CMO)
Partnering
Internationalization
R&D
One-stop service
Provide what you want
News
Press releases
Careers
Join us
Our Employees
Incentives
Opportunities
Investors
Investor contact
Contact us
十大网投靠谱平台
|
LD.COM乐动官网(中国)有限公司
|
华亿体育(中国)股份有限公司
|
天博网页版【游戏】有限公司
|
博鱼app(中国)官方网站
|
华体app网页版(中国)有限公司
|
168体育官方网站丨中国有限公司
|
澳亚娱乐游戏(中国)官方有限公司
|
乐竞体育(中国)股份有限公司
|